ARCHIVES

Appeals Court Overturns FDA Approval Of Generic Paclitaxel, A Setback For Ivax.

This article is from The Cancer Letter archive.

Vol. 27 No. 41 | November 9, 2001

Download PDF Visit The Full Archive

Related Articles

Budget Would Support 1,211 More Grants

February 7, 2003

Senate Appropriations Report Language On NCI, NIH Budgets

September 20, 1996

FASEB Urges Better Funding, Management Of Biomedical Research

February 23, 1996

FDA Didn’t Punish Duke for Failing To Seek Proper Regulatory Clearance for Three Trials

January 27, 2012

ACS To Implement Cancer Response Systems Nationwide

August 2, 1985

Cancer Accounts for 23% of U.S. Deaths, American Cancer Society Says.

January 21, 2005